AOC3 and atherosclerosis: Furthermore, it has been shown that diabetic/atherosclerosis mice treated with a VAP-1/SSAO inhibitor exhibit increases in urinary methylamine and decreases in FA and MDA in the urine and atherosclerotic lesions47.